JESSICA DLUGOLECKI: Open Payments
NPI 1841867603 · CHITTENANGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 15 payments from 10 companies in 2025. Trend: 2023 $250 · 2024 $260 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $97 |
| Corcept Therapeutics | 1 | $36 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| Seqirus USA Inc | 1 | $34 |
| Insulet Corporation | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| SHIELD THERAPEUTICS INC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Ozempic, Korlym, TRELEGY ELLIPTA, Flucelvax, Omnipod, INSPIRE, ACCRUFER, Auvelity.
Industry payments across NY — which companies pay providers there.
